CHI to Debut Drug Delivery & Formulation Meeting at World Pharma Congress 2013

The Accelerating Development of Difficult-to-Deliver Drugs conference will discuss the role of novel delivery strategies and advanced tools in developing difficult-to-deliver drugs.
 
 
Spread the Word
Listed Under

Tags:
* Drug Formulation
* Nanodelivery

Industrys:
* Biotech
* Science

Location:
* Needham - Massachusetts - US

Feb. 22, 2013 - PRLog -- Cambridge Healthtech Institute will debut its inaugural Accelerating Development of Difficult-to-Deliver Drugs conference at the 12th annual World Pharma Congress.  Taking place June 4-6 in Philadelphia, PA, this conference will discuss the role of novel delivery strategies and advanced tools in developing difficult-to-deliver drugs, designing targeted delivery approaches, improving efficacy and safety, and leading to overall patient compliant therapies.

Formulation and Drug Delivery thought-leaders from both pharma and academia will present latest research, developments, and expertise in aspects of drug delivery including nanotechnology, nanoparticles, bioavailability, next-gen protein delivery, and more.

The distinguished faculty at this conference includes:

- Vladimir Torchilin, Ph.D., D.Sc., University Distinguished Professor, Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University

- Philip S. Low, Ph.D., Ralph C. Corley Distinguished Professor, Department of Chemistry, Purdue University

- Munir Hussain, Ph.D., Distinguished Research Fellow, Drug Product Science & Technology, Bristol-Myers Squibb Co.

- Anil K. Patri, Ph.D., Deputy Director, Nanotechnology Characterization, Laboratory, Advanced Technology Program, SAIC-Frederick, Inc.,National Laboratory for Cancer Research

- Uma Prabhakar, Ph.D., Consultant, Office of Cancer Nanotechnology Research NCI-NIH

- Karyn O’Neil, Ph.D., Chief Scientific Officer of Centyrex Venture, Johnson & Johnson

- Jeff Hrkach, Ph.D.  Vice President, R & D, Bind Bio Science

- Samir Mitragotri, Ph.D., Professor, Chemical Engineering, University of California, Santa Barbara

- Bobby Singh, Ph.D., Chief Technology Officer, Corium International, Inc.

- Karim Dabbagh, Ph.D., Executive Director and Head, External R&D and Innovation Research Units, Pfizer Worldwide R&D

- Tycho Heimbach, Ph.D., Associate Director & Senior Investigator II, Biomedical Research, Novartis Pharmaceuticals Corporation

- And more!

Why Should Scientists and Executives Interested in Drug Delivery Attend This Conference?

- Join in discussions and learn practical strategies from distinguished professors and industry experts from NCI-NIH, BMS, Merck, Novartis, J& J, BIND Biosciences, BI, Cubist and more.

- Hear case studies and novel approaches in Preformulation, drug targeting and next gen delivery of biologics

- Learn how to overcome the bioavailability hurdles for poorly soluble drugs with new technologies and tools.

The final agenda is set, and is available online at www.worldpharmacongress.com/Formulation-Drug-Delivery.  There is an early registration discount of up to $350 available until March 1.
End
Source:
Email:***@healthtech.com Email Verified
Phone:781.972.5400
Zip:02494
Tags:Drug Formulation, Nanodelivery
Industry:Biotech, Science
Location:Needham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute News
Trending
Daily News
Weekly News



Like PRLog?
9K2K1K
Click to Share